Sabra Health Care REIT (NASDAQ:SBRA) is scheduled to be posting its Q4 2017 quarterly earnings results after the market closes on Wednesday, February 21st. Analysts expect Sabra Health Care REIT to post earnings of $0.30 per share for the quarter.
Sabra Health Care REIT (NASDAQ SBRA) opened at $17.00 on Monday. Sabra Health Care REIT has a 1-year low of $15.77 and a 1-year high of $29.10. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a market capitalization of $3,030.00, a PE ratio of 21.79, a price-to-earnings-growth ratio of 2.32 and a beta of 0.74.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 10.59%. The ex-dividend date of this dividend is Wednesday, February 14th. Sabra Health Care REIT’s dividend payout ratio is 230.77%.
In related news, Director Milton J. Walters sold 4,615 shares of the stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $19.18, for a total transaction of $88,515.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.60% of the company’s stock.
A number of research analysts have weighed in on the company. Zacks Investment Research downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $22.00 price objective on shares of Sabra Health Care REIT in a research note on Friday, November 3rd. Raymond James Financial reaffirmed a “hold” rating on shares of Sabra Health Care REIT in a research note on Wednesday, December 13th. TheStreet downgraded Sabra Health Care REIT from a “b-” rating to a “c” rating in a research note on Friday, November 3rd. Finally, SunTrust Banks reaffirmed a “buy” rating and issued a $25.00 price objective on shares of Sabra Health Care REIT in a research note on Friday, November 3rd. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $24.10.
TRADEMARK VIOLATION NOTICE: “Sabra Health Care REIT (SBRA) to Release Earnings on Wednesday” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/19/sabra-health-care-reit-sbra-to-release-earnings-on-wednesday-2.html.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.